Gabrielle A. Silver - Jun 14, 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Dr. Gabrielle A. Silver
Stock symbol
OPNT
Transactions as of
Jun 14, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 04:51 PM
Previous filing
May 17, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Award $0 +2K +9.37% $0.00 23.3K Jun 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date.